Evidence map›Paper›PMID 39697094›Full record

Trial reportNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2025

Exploring Gender Differences in Receipt of the 5As for Smoking Cessation for Recently Diagnosed Cancer Patients (ECOG-ACRIN EAQ171CD).

Lucy Finkelstein-Fox, JoRean D Sicks, Lynne I Wagner, Ruth C Carlos, Isabelle L Miranda, Rachel L Rosen, Maria Lopes, Brett M Goshe, Ilana F Gareen, Benjamin A Herman and 12 more

Registry-linked trialAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03808818 (Implementing a Virtual Tobacco Treatment in Community Oncology Practices), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03808818 nacompletednot on this map

Implementing a Virtual Tobacco Treatment in Community Oncology Practices: "Smoke Free Support Study 2.0"

TypeinterventionalSponsorECOG-ACRIN Cancer Research GroupRan2019 to 2023Enrolled306ConditionsCarcinoma In Situ, Current Smoker, Malignant Neoplasm, Primary NeoplasmArmsBehavioral, Psychological or Informational Intervention, Nicotine Replacement, Quality-of-Life Assessment, Survey Administration, Tobacco Cessation Counseling
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Lucy Finkelstein-FoxHealth Promotion and Resiliency Intervention Research Center (HPRIR), Department of Psychiatry, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.ORCID 0000-0001-7799-9164
JoRean D SicksCenter for Statistical Sciences, Brown University School of Public Health, Providence, RI, USA.
Lynne I WagnerDepartment of Health Policy and Management, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC, USA.
Ruth C CarlosDepartment of Radiology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.ORCID 0000-0001-7055-7662
Isabelle L MirandaHealth Promotion and Resiliency Intervention Research Center (HPRIR), Department of Psychiatry, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.
Rachel L RosenHealth Promotion and Resiliency Intervention Research Center (HPRIR), Department of Psychiatry, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.
Maria LopesDepartment of Psychology, University of Miami, Coral Gables, FL, USA.
Brett M GosheHealth Promotion and Resiliency Intervention Research Center (HPRIR), Department of Psychiatry, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.
Ilana F GareenCenter for Statistical Sciences, Brown University School of Public Health, Providence, RI, USA.
Benjamin A HermanCenter for Statistical Sciences, Brown University School of Public Health, Providence, RI, USA.
Alexander TauroneCenter for Statistical Sciences, Brown University School of Public Health, Providence, RI, USA.
Angela Wangari WalterDepartment of Public Health, Zuckerberg College of Health Sciences, University of Massachusetts Lowell, Lowell, MA, USA.ORCID 0000-0003-0098-6802
Autumn W RasmussenDepartment of Clinical Psychology, William James College, Newton, MA, USA.
Douglas E LevyMongan Institute, Department of Medicine, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.ORCID 0000-0001-9446-7899
Michael A ThompsonTempus Labs, Inc, Chicago, IL, USA.
Laura MalloyHealth Promotion and Resiliency Intervention Research Center (HPRIR), Department of Psychiatry, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.
Irina GonzalezHealth Promotion and Resiliency Intervention Research Center (HPRIR), Department of Psychiatry, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-4570-1313
Brian L BurnetteCancer Research of Wisconsin and Northern Michigan (CROWN) - NCORP, Saint Vincent Hospital Cancer Center, Green Bay, WI, USA.
Alyssa D ThrockmortonMultidisciplinary Breast Program, Baptist Cancer Center, Memphis, TN, USA.
Martha S TingenDepartment of Medicine, Augusta University Medical College of Georgia, Augusta, GA, USA.
Jamie S OstroffDepartment of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Elyse R ParkHealth Promotion and Resiliency Intervention Research Center (HPRIR), Department of Psychiatry, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-6319-264X

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
ECOG-ACRIN NCORP Research Base - TMISTUG1CA189828 · NCI · ECOG-ACRIN MEDICAL RESEARCH FOUNDATION · PI Peter J ODwyer, MITCHELL D. SCHNALL · 2014 to 2026
$199.7M
Metro-Minnesota Community Oncology Research Consortium (MMCORC)UG1CA189863 · NCI · PARK NICOLLET INSTITUTE · PI JOLEEN M HUBBARD, Yan Ji · 2014 to 2026
$43.2M
Wisconsin NCI Community Oncology Research Program (WiNCORP)UG1CA189956 · NCI · MARSHFIELD CLINIC RESEARCH FOUNDATION · PI ADEDAYO A ONITILO, Kurt Oettel · 2014 to 2026
$32.3M
Cancer Research of Wisconsin and Northern Michigan (CROWN) ConsortiumUG1CA239769 · NCI · ST. VINCENT HOSPITAL · PI Anthony J Jaslowski · 2019 to 2026
$15.8M
Iowa-Wide Oncology Research Coalition (I-WORC)UG1CA189816 · NCI · IOWA ONCOLOGY RESEARCH ASSOCIATION · PI Seema Harichand, Arshin Sheybani · 2014 to 2026
$14.9M
Ozark Health Ventures, LLC dba Cancer Research for the Ozarks (CRO)UG1CA189822 · NCI · OZARK HEALTH VENTURES, LLC · PI Jay W Carlson · 2014 to 2026
$14.2M
Georgia CaResUG1CA189851 · NCI · AUGUSTA UNIVERSITY · PI Anand P Jillella · 2014 to 2026
$13.3M
Baptist Memorial Health Care/Mid South NCORP Minority Underserved ConsortiumUG1CA189873 · NCI · BAPTIST MEMORIAL HOSPITAL - TIPTON · PI Raymond U. Osarogiagbon · 2014 to 2026
$11.9M
Research Training in Complementary and Integrative MedicineT32AT000051 · NCCIH · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI GLORIA Y YEH · 1999 to 2026
$10.2M
Columbus NCORP RFA-CA-18-016UG1CA189954 · NCI · COLUMBUS COMMUNITY CLINICAL ONCOLOGY PRG · PI Aruna Gowda, Malolan S Rajagopalan · 2014 to 2026
$9.8M
Organizational readiness and engagement of community oncology practices in implementing tobacco use assessment and treatmentR01CA214427 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI OSTROFF, JAMIE S., PARK, ELYSE R. · 2018 to 2023
$3.5M
American Cancer Society CSDG-23-1152971-01-CSCTNational Cancer Institute of the National Institutes of Health P30CA008748National Cancer Institute of the National Institutes of Health R01CA214427National Cancer Institute of the National Institutes of Health UG1CA189816National Cancer Institute of the National Institutes of Health UG1CA189822National Cancer Institute of the National Institutes of Health UG1CA189828National Cancer Institute of the National Institutes of Health UG1CA189851National Cancer Institute of the National Institutes of Health UG1CA189863National Cancer Institute of the National Institutes of Health UG1CA189873National Cancer Institute of the National Institutes of Health UG1CA189954National Cancer Institute of the National Institutes of Health UG1CA189956National Cancer Institute of the National Institutes of Health UG1CA239769NCCIH NIH HHS T32 AT000051NCCIH NIH HHS T32AT000051NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA214427NCI NIH HHS UG1 CA189816NCI NIH HHS UG1 CA189822NCI NIH HHS UG1 CA189828NCI NIH HHS UG1 CA189851NCI NIH HHS UG1 CA189863NCI NIH HHS UG1 CA189873NCI NIH HHS UG1 CA189954NCI NIH HHS UG1 CA189956NCI NIH HHS UG1 CA239769
6 · The paper itself

Abstract

introductionSmoking cessation is important for men and women diagnosed with cancer. Oncology clinicians should encourage all patients to quit and offer resources to help them do so, following the 5As framework (Ask, Advise, Assess, Assist, and Arrange follow-up). AIMS AND

methodsThis study tests gender differences in self-reported receipt of the 5As from an oncology provider among 306 recently diagnosed male and female cancer patients. Receipt of praise for quitting efforts was also assessed as an indicator of empathic communication. Participants completed baseline surveys as part of a larger clinical trial focused on smoking cessation (NCT03808818), reflecting on pretrial interactions with their oncology clinicians.

resultsMost male and female patients received "Ask," "Advise," and "Assess" (ie, asking patients if they smoke, advising them to quit, and assessing their interest in doing so), though significant gender differences emerged in receiving "Assist" and "Arrange follow-up." Women were less likely to receive assistance (eg, medication or counseling referral; 85.25% vs. 93.18%, respectively) or a follow-up appointment to discuss their progress (28.11% vs. 40.91%, respectively). Approximately half of men and women were praised for their quitting efforts. In exploratory sensitivity analyses, gender differences in "Arrange follow-up" were attenuated when adjusting for cancer location (smoking-related or not), self-reported distress, and self-reported coping ability.

conclusionsWomen may be at risk for suboptimal smoking-related support during cancer care, as assistance and follow-up are essential to sustained abstinence. Clinicians should consistently deliver each of the 5As to all cancer patients who smoke, regardless of cancer type or expressed distress/coping difficulty. IMPLICATIONS: The current study findings add to the growing literature describing gender disparities in tobacco treatment access. Findings highlight an addressable gap in access to tobacco treatment for a group of women who have cancer. Advancements in the equitable delivery of smoking cessation counseling have the potential to improve cessation outcomes for women with cancer who smoke.

Indexed as

NeoplasmsSmoking CessationAdultAgedCounselingFemaleHumansMaleMiddle AgedSex FactorsSurveys and Questionnaires

Identifiers

PMID39697094
PMCPMC12539916

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.